TP53 and neoplasm: Importantly, TP53/RB1 co‐alteration synergistically disrupts DNA damage response and cell cycle regulation, thereby fostering genomic instability, uncontrolled proliferation, and accelerating malignant transformation and tumor evolution [2, 3].